Octave Bioscience's guest appearances

Octave Bioscience

Entrepreneurial Thought Leaders

Empowered Patient Podcast

Entrepreneurial Thought Leaders Video Series

The Alldus Podcast - AI in Action

Women to Watch Media® with Sue Rocco

SheLeads with Carly

OwlTail

Melinda Thomas

Melinda Thomas, COO &amp; Co-Founder of Octave Bioscience, shared the story behind her title with us on August 14, 2022.Melinda has over two decades of experience starting and leading health companies. Using her expertise, she wraps a company around a technical/scientific team so they can focus on meeting the company’s milestones. Melinda built CardioDx, a molecular diagnostics company specializing in cardiovascular genomics, and ParAllele, high-throughput sequencing and SNP discovery company, from the foundation point. ParAllele was acquired by Affymetrix in what one investor said was their best investment of the decade. Previously, she served as the Inaugural Entrepreneur in Residence for New York City, solving problems for aspiring entrepreneurs, and as Chair of the Board for the Save the Redwoods League. Before ParAllele, she guided Molecular Dynamics Manufacturing, building it from an 8-person to an 85-person manufacturing organization. Melinda holds an MBA from Harvard and a BS from UC Berkeley.SUE SAYS"Melinda Thomas' life and career journey was one of saying yes to opportunities that presented themselves to her. From when she was seven and said sure, I'll help the neighbor build that cinderblock grease pit to saying yes to the multiple opportunities to launch new companies. It's always been a matter of following her gut and wanting to learn new things. Learn why she and her co-Founder decided to tackle the most complex neurological disease first when launching Octave."Support this podcast at — https://redcircle.com/women-to-watch-r/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy &amp; Opt-Out: https://redcircle.com/privacy

Melinda Thomas,<a href="https://www.octavebio.com/" rel="nofollow" target="_blank"> COO &amp; Co-Founder of Octave Bioscience</a>, shared the story behind her title with us on August 14, 2022.Melinda has over two decades of experience starting and leading health companies. Using her expertise, she wraps a company around a technical/scientific team so they can focus on meeting the company’s milestones. Melinda built CardioDx, a molecular diagnostics company specializing in cardiovascular genomics, and ParAllele, high-throughput sequencing and SNP discovery company, from the foundation point. ParAllele was acquired by Affymetrix in what one investor said was their best investment of the decade. Previously, she served as the Inaugural Entrepreneur in Residence for New York City, solving problems for aspiring entrepreneurs, and as Chair of the Board for the Save the Redwoods League. Before ParAllele, she guided Molecular Dynamics Manufacturing, building it from an 8-person to an 85-person manufacturing organization. Melinda holds an MBA from Harvard and a BS from UC Berkeley.<h4><a href="https://women2watch.net/about/founder/" rel="nofollow" target="_blank">SUE </a>SAYS</h4>"Melinda Thomas' life and career journey was one of saying yes to opportunities that presented themselves to her. From when she was seven and said sure, I'll help the neighbor build that cinderblock grease pit to saying yes to the multiple opportunities to launch new companies. It's always been a matter of following her gut and wanting to learn new things. Learn why she and her co-Founder decided to tackle the most complex neurological disease first when launching Octave."Support this podcast at — <a href="https://redcircle.com/women-to-watch-r/donations" rel="payment nofollow" target="_blank">https://redcircle.com/women-to-watch-r/donations</a> Advertising Inquiries: <a href="https://redcircle.com/brands" rel="nofollow" target="_blank">https://redcircle.com/brands</a> Privacy &amp; Opt-Out: <a href="https://redcircle.com/privacy" rel="nofollow" target="_blank">https://redcircle.com/privacy</a>

Melinda Thomas, Octave Bioscience

Today's guest is Erwan Rivet, Chief Technology Officer at Octave Bioscience in California. Octave is developing a comprehensive, first-in-class Care Management Platform. The team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. They are tackling neurodegenerative diseases -- starting with multiple sclerosis (MS). Octave believe that to dramatically improve outcomes, they need to improve care management. The challenges for MS are significant, the issues are overwhelming and the needs are mostly unmet. That’s why Octave is creating a comprehensive, measurement-driven care management platform for MS. Finally, stakeholders need better information that is highly actionable. Octave’s three layer model of biological, clinical, and economic data combined with sophisticated analytics, contextualization, machine learning and AI provide new insights for physicians, patients, payers and pharma. In the episode, Erwan will chat about: The impact Octave are making in the healthcare sector, Interesting projects they are working on within MS and medical imaging, Building and scaling the data science team, The importance of collaboration between data science and data engineering, Day-to-day life and challenges they are solving in the data team &amp; What the future holds for Octave

Today's guest is Erwan Rivet, Chief Technology Officer at <a href="https://www.octavebio.com/" rel="noopener nofollow" target="_blank">Octave Bioscience</a> in California. Octave is developing a comprehensive, first-in-class Care Management Platform. The team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. They are tackling neurodegenerative diseases -- starting with multiple sclerosis (MS). Octave believe that to dramatically improve outcomes, they need to improve care management. The challenges for MS are significant, the issues are overwhelming and the needs are mostly unmet. That’s why Octave is creating a comprehensive, measurement-driven care management platform for MS. Finally, stakeholders need better information that is highly actionable. Octave’s three layer model of biological, clinical, and economic data combined with sophisticated analytics, contextualization, machine learning and AI provide new insights for physicians, patients, payers and pharma. In the episode, Erwan will chat about: The impact Octave are making in the healthcare sector, Interesting projects they are working on within MS and medical imaging, Building and scaling the data science team, The importance of collaboration between data science and data engineering, Day-to-day life and challenges they are solving in the data team &amp; What the future holds for Octave

E271 Erwan Rivet, Chief Technology Officer at Octave Bioscience

Bill Hagstrom is the CEO and Founder of Octave Bioscience, looking at ways to dynamically assess patients with multiple sclerosis and other neurodegenerative diseases to manage their treatment plan better. Bill says, "There's an enormous opportunity to take a personalized approach to managing these patients. MS and these other neurodegenerative diseases are known to have a lot of heterogeneity and have trajectories that can vary dramatically." At the same time, Octave is developing pathway models so a physician can see where a patient is in their overall journey and look at acute decision nodes, and access decision support tools. #OctaveBioscience #personalizedmedicine #MS #multiplesclerosis #neurodegenerativediseases #bloodbasedbiomarkers #biomarkers #symptomology #digitalhealth  OctaveBio.com Download the transcript here

Bill Hagstrom is the CEO and Founder of Octave Bioscience, looking at ways to dynamically assess patients with multiple sclerosis and other neurodegenerative diseases to manage their treatment plan better. Bill says, "There's an enormous opportunity to take a personalized approach to managing these patients. MS and these other neurodegenerative diseases are known to have a lot of heterogeneity and have trajectories that can vary dramatically." At the same time, Octave is developing pathway models so a physician can see where a patient is in their overall journey and look at acute decision nodes, and access decision support tools. #OctaveBioscience #personalizedmedicine #MS #multiplesclerosis #neurodegenerativediseases #bloodbasedbiomarkers #biomarkers #symptomology #digitalhealth  <a href="http://OctaveBio.com" rel="noopener nofollow" target="_blank">OctaveBio.com</a> <a href="http://empoweredpatientradio.com/personalized-approach-to-measuring-and-managing-ms-and-other-neurodegenerative-diseases-with-bill-hagstrom-octave-bioscience-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Personalized Approach to Measuring and Managing MS and Other Neurodegenerative Diseases with Bill Hagstrom Octave Bioscience

Melinda Thomas is the Co-Founder and COO of Octave Bioscience, a company aiming to improve outcomes in neurodegenerative diseases. Melinda discusses key aspects in leadership. Key themes include practicing the 80/20 Rule, having a bias towards action, and never lowering the bar when hiring - even when push comes to shove.

Melinda Thomas is the Co-Founder and COO of Octave Bioscience, a company aiming to improve outcomes in neurodegenerative diseases. Melinda discusses key aspects in leadership. Key themes include practicing the 80/20 Rule, having a bias towards action, and never lowering the bar when hiring - even when push comes to shove.

10: Melinda Thomas | Co-founder and COO, Octave Bioscience

Drawing on her experience launching and leading health companies like CardioDx and ParAllele, Melinda Thomas co-founded Octave Bioscience in 2014. Octave is developing a care management platform for neurodegenerative diseases, starting with multiple sclerosis, and aims to improve patient management decisions and create better outcomes while also lowering costs. In this talk, Thomas offers strategies for building deep, skills-driven entrepreneurial confidence.

Drawing on her experience launching and leading health companies like CardioDx and ParAllele, Melinda Thomas co-founded Octave Bioscience in 2014. Octave is developing a care management platform for neurodegenerative diseases, starting with multiple sclerosis, and aims to improve patient management decisions and create better outcomes while also lowering costs. In this talk, Thomas offers strategies for building deep, skills-driven entrepreneurial confidence.